Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2017-03-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
第三届董事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fourth meeting of the third board of directors of Changchun Dirui Medical Technology Co., Ltd. It includes approvals of various reports and proposals related to the 2016 fiscal year, such as the general manager's work report, board work report, financial report, profit distribution plan, and other governance matters. However, the actual reports and detailed financial statements are referenced as being available on an external website (www.cninfo.com.cn) rather than included in the document itself. The document also states that many of these items will be submitted to the 2016 annual general meeting for approval. The document length is 3568 characters, which is relatively short and mainly serves as a meeting resolution announcement rather than containing the full annual report or financial statements. According to the "Menu vs Meal" rule, since the document references the reports and states they are available elsewhere, and the document is relatively short, it should be classified as a Regulatory Filing (RNS) rather than the Annual Report (10-K) or Management Report (MDA). It is not a proxy solicitation or voting results announcement, but a board meeting resolution announcement. Therefore, the best fitting category is Regulatory Filings (RNS).
2017-03-24 Chinese
2016年年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (323 characters) indicating that the full 2016 Annual Report of the company has been disclosed on a regulatory website. It explicitly states that the full report is available elsewhere and investors should refer to it. This matches the pattern of a Report Publication Announcement (RPA), not the full Annual Report itself. The document does not contain financial data or detailed report content, only a notice of publication.
2017-03-24 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates for 13 chemiluminescence in vitro diagnostic reagent products. It includes product names, registration numbers, validity periods, classifications, and clinical uses. The document is a formal disclosure by the company's board ensuring the accuracy and completeness of the information. There is no financial data, no mention of financial results, no discussion of management changes, no voting results, no legal proceedings, no capital changes, and no regulatory certifications or attestations. The document is relatively short (2620 characters) and is an announcement of a regulatory approval event related to product registration. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-03-20 Chinese
关于变更财务顾问主办人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in the company's financial advisor lead person related to a previously completed major asset acquisition. It does not contain financial statements or detailed financial data. It is not a full report but an update on management of financial advisory services for a past transaction. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like Annual Report, Interim Report, or Capital Update.
2017-03-15 Chinese
关于使用闲置自有资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's use of idle funds to purchase wealth management products. It details the investment amounts, product types, expected yields, risk disclosures, risk control measures, and the impact on the company. The document is relatively short (3370 characters) and is an announcement of financial activity related to capital management rather than a full financial report or earnings release. It does not contain comprehensive financial statements or quarterly results. The content fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities involving investment of idle funds into financial products.
2017-03-02 Chinese
2016年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2016 年度业绩快报' which translates to '2016 Annual Performance Express Report' or '2016 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2016, including revenue, profit, net income, and other financial metrics. The document explicitly states that the data is preliminary, unaudited, and subject to change in the final annual report. It also mentions that the detailed audited financial data will be disclosed in the 2016 annual report. The document length is 1717 characters, which is relatively short and consistent with a brief earnings release or performance summary rather than a full annual report. The document is not a full annual report (10-K) because it lacks comprehensive audited financial statements and detailed disclosures. It is not an announcement of the report publication (RPA) because it contains substantive preliminary financial data, not just a notice. Therefore, this document fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2016
2017-02-22 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.